dHMN-VWA1

VWA1 | 2021

What Is dHMN-VWA1?

dHMN-VWA1 is a type of CMT caused by autosomal recessive mutations in the VWA1 gene. This gene provides instructions for making a protein of the extracellular matrix that supports the structure surrounding motor nerve cells. Mutations in the VWA1 gene disrupt this function, leading to impaired nerve signal transmission.

dHMN-VWA1 is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in dHMN-VWA1 is variable, ranging from childhood to adulthood. As a motor neuropathy, dHMN-VWA1 primarily affects the most distal points, with weakness and atrophy of the feet and hands, and little to no involvement of the sensory nerves. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dHMN-VWA1 symptoms may include:

  • Weakness and atrophy in the feet and lower legs
  • Foot drop
  • Reduced or absent reflexes
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dHMN-VWA1 shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dHMN-VWA1

Classification
dHMN/HMN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
VWA1

Gene Full Name
Von Willebrand Factor a Domain Containing 1

HGNC Gene Alias(es)
WARP

Chromosome
1p36.33

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Biallelic

Confidence:
High

Prediction:
The literature predicts a biallelic loss-of-function mechanism for dHMN-VWA1: recessive truncating variants in VWA1 (notably the founder frameshift c.62_71dup) abolish or severely reduce the secreted extracellular-matrix protein WARP, so both alleles must be lost and restored wild-type is predicted to rescue. Convergent genetic and functional evidence supports simple loss rather than a dominant-negative or gain-of-function effect.

Rationale:
Biallelic truncating VWA1 variants (notably the founder c.62_71dup) abolish the secreted WARP protein, so restored wild-type is predicted to rescue: a biallelic loss of function, with no dominant-negative or gain-of-function contribution.

ClinVar Pathogenic Variants

View dHMN-VWA1 ClinVar Variants

dHMN-VWA1 OMIM Entry

dHMN-VWA1 OMIM

VWA1 OMIM Entry

VWA1 OMIM

More Info

dHMN-VWA1 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

An Ancestral 10-bp Repeat Expansion in VWA1 Causes Recessive Hereditary Motor Neuropathy

Authors

Pagnamenta, A. T., Kaiyrzhanov, R., Zou, Y., Da’as, S. I., Maroofian, R., Donkervoort, S., Dominik, N., Lauffer, M., Ferla, M. P., Orioli, A., Giess, A., Tucci, A., Beetz, C., Sedghi, M., Ansari, B., Barresi, R., Basiri, K., Cortese, A., Elgar, G., Fernandez-Garcia, M. A., … Houlden, H.

Publication Date
January 18, 2021

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Jean-Martin Charcot lecturing at the Salpêtrière while comparing anatomical illustrations of a cavovarus Charcot-Marie-Tooth (CMT) foot and a Charcot neuroarthropathy foot, highlighting two different conditions that share the Charcot name.


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.